SIGN UP
LOG IN
R
REGN
Regeneron Pharmaceuticals
558.87
13.41+2.46%After Hours: 561.00 +2.13 +0.38%19:46 08/01 EDT
OPEN/PREV CLOSE583.01/545.46
TODAY RANGE542.89-583.28
VOL1.66M
MARKET CAP60.34B
52 WEEK RANGE476.49-1,207.86
AVG VOL (3M)1.25M
% TURNOVER1.53%
TURNOVER--
P/E (TTM)14.08
% RANGE7.40%
EPS(TTM)39.70
P/E(FORWARD)19.13
P/B1.986
BVPS281.38
DIVIDEND3.520
P/S4.313
BETA--
DIV YIELD0.63%
FREE FLOAT MKT CAP58.15B
SHARES OUTSTANDING107.97M
NEXT EARNINGS10/29-11/03
FREE FLOAT104.04M
LOT SIZE1
EX-DATE05/20/2025
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
Regeneron Pharmaceuticals Reports Strong Q2 2025 Results
TipRanks·1d ago
Regeneron Earnings Call: Growth Amid Challenges
Seeking Alpha·1d ago
Regeneron: Rapidly Decreasing Importance Of Eylea
Seeking Alpha·1d ago
Regeneron lymphoma therapy odronextamab rejected by FDA again
Seeking Alpha·1d ago
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Benzinga·1d ago
Stocks Sell Off, Gold Rallies On Tariff Turmoil, Weak Jobs Data: What's Moving Markets Friday?
TipRanks·1d ago
Regeneron’s New Study on MASH: A Potential Game-Changer?
TipRanks·1d ago
Regeneron’s Phase 3 Trial: A New Hope for Lymphoma Treatment
NASDAQ·1d ago
Nasdaq 100 Movers: MRVL, REGN
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.